Chiral Technology: Global Markets

Mar 2010| BIO012E| BCC Publishing

Report Highlights

  • Global sales of chiral technology products in 2008 were $4.3 billion and with 3.3% growth, the sales reached $4.5 billion in 2009. This market is expected to rise at a compound annual growth rate (CAGR) of 2.8% and reach $5.1 billion by 2014.
  • The chiral technology market is led by chiral synthesis products with more than 80% share. This sector was worth $3.6 billion in 2009 and is projected to increase at a  2.2% compound annual growth rate (CAGR) to $4 billion in 2014.
  • The chiral analysis market was valued at $714 million in 2009. This segment is estimated to grow at a compound annual growth rate (CAGR) of 5.5% to reach $936 million in 2014.

INTRODUCTION 

STUDY OBJECTIVES
 
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for chiral products and technologies used in today’s world. The key objective is to present a comprehensive analysis of the current market and its future direction in the chiral market as an important tool for diagnosis of various diseases.
 
This report explores present and future strategies within the chiral market, including the synthesis, separation, and analysis of the chiral products. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. An overview of chirality, the chiral products, and the technologies used in past and present are depicted in the report.
 
A detailed analysis of the chiral industry structure has been conducted. This includes the chiral synthesis, chiral separation/resolution, and the chiral analysis. Revenues are broken down by the region. Sales figures are estimated for the 5-year period from 2009 through 2014.
 
Applications for chiral products and technologies are also discussed separately in the report, with emphasis of the usage in pharmaceutical, biochemical, and agrochemical industries. The report also covers significant patents and their allotments in each category.
 
REASONS FOR DOING THIS STUDY
 
This study was conducted to provide an update of new developments in the chiral technology market. The previous report covered only the U.S. market, but this study covers the global market of chiral products. This study was conducted to provide detailed market analysis of chiral-enabling products along with the factors affecting this market. As for other industries, this industry also saw some setback in 2008, due to the economic downturn, but the new advancements and the need for enantiopure compounds have always influenced the market to grow. This study looks at almost all the systems affected by these factors.
 
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each system/technology in light of the new technologies, growing competition, and changing customer needs.
 
INTENDED AUDIENCE
 
This study contributes to the areas of market growth in diagnosis through chiral products and technologies from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.
 
SCOPE OF THE STUDY
 
The scope of this study encompasses imaging, diagnosing, and medical markets. BCC analyzes each market and its applications by its need for diagnosis through imaging, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
 
METHODOLOGY
 
Both primary and secondary research methodologies were used to prepare this report. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
 
INFORMATION SOURCES
 
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of chiral products. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
 
ABOUT THE AUTHOR
 
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service.  BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.  

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Chiral Technology: Global Markets171Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY 3Free
Chapter- 3: OVERVIEW6Free
Chapter- 4: CHIRAL TECHNOLOGY14Free
Chapter- 5: IMPORTANCE OF CHIRALITY3Free
Chapter- 6: REGULATORY ASPECTS5Free
Chapter- 7: INDUSTRY STRUCTURE19Free
Chapter- 8: NEW DEVELOPMENTS10Free
Chapter- 9: THE CHIRAL SYNTHESIS MARKET14Free
Chapter- 10: THE CHIRAL SEPARATION MARKET12Free
Chapter- 11: CHIRAL ANALYSIS MARKET17Free
Chapter- 12: MARKET BY APPLICATIONS 20Free
Chapter- 13: PATENT ANALYSIS13Free
Chapter- 14: CURRENT SITUATION OF THE CHIRAL MARKET6Free
Chapter- 15: C. CRAMER & CO. GMBH24Free
Chapter- 16: APPENDIX 1Free
Published - Feb-2004| Analyst - Shalini Shahani Dewan| Code - BIO012D

Report Highlights

  • The total U.S. market for chiral technology reached $1.2 billion in 2003. Rising at an average annual growth rate (AAGR) of 8.8%, this market is expected to exceed $1.8 billion in 2008.
  • Chiral manufacturing dominates, with revenues of more than $1 billion in 2003 and rising to $1.6 billion at an AAGR of 9.2% in 2008.
  • The chiral analysis market was $164.6 million by 2003 and should rise to $226.4 million by 2008, for an AAGR of 6.6%.
  • The worldwide market for chiral-enabling products was expected to reach $2,998 million by the end of 2003 and rise at an AAGR of 9.1% through 2008.

Published - Jun-2000| Analyst - Charles Forman| Code - BIO012C

Report Highlights

  • Manufactured enantiomeric products, produced either by racemate separation (resolution, the dominant technology to date) or by specific chiral synthesis to produce single isomer products. Although chiral resolution still is the dominant commercial technology, the value of its enabling products is much less. It only was about $103 million in 1999, compared to more than $1.6 billion that year for chiral synthesis-enabling products. The reason lies in the recovery and reuse of most separation products and the high cost (and use) of chiral chemical intermediates; the latter are the single, largest type of chiral enabling product at about $1.6 billion in 1999. We forecast continued healthy growth for all chiral manufacturing products, from a total of $1.75 billion in 1999 to almost $2.8 billion in 2004, at an average annual growth rate (AAGR) of almost 10%.
  • Chiral analysis products are materials that enable scientists to analyze chiral products and mixtures. This market, valued at about $160 million in 1999 and growing at 5.5% overall to $209 million in 2004. It is dominated by analytical chromatography, especially liquid chromatography (mainly HPLC). This latter technology accounted for $121 million of the 1999 market.

Chiral Technology: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS